0001213900-22-049413.txt : 20220818 0001213900-22-049413.hdr.sgml : 20220818 20220818172617 ACCESSION NUMBER: 0001213900-22-049413 CONFORMED SUBMISSION TYPE: 20-F/A PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Happiness Development Group Ltd CENTRAL INDEX KEY: 0001751876 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 20-F/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39098 FILM NUMBER: 221178206 BUSINESS ADDRESS: STREET 1: NO. 11, DONGJIAO EAST ROAD, SHUANGXI STREET 2: SHUNCHANG CITY: NANPING, STATE: F4 ZIP: 353001 BUSINESS PHONE: 86-0599-782-8808 MAIL ADDRESS: STREET 1: NO. 11, DONGJIAO EAST ROAD, SHUANGXI STREET 2: SHUNCHANG CITY: NANPING, STATE: F4 ZIP: 353001 FORMER COMPANY: FORMER CONFORMED NAME: Happiness Biotech Group Ltd DATE OF NAME CHANGE: 20180831 20-F/A 1 f20f2022a1_happinessdev.htm AMENDMENT NO.1 TO FORM 20-F

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

AMENDMENT NO.1 TO

FORM 20-F

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended March 31, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                            to                           

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report

 

Commission file number: 001-39098

 

Happiness Development Group Limited

(Exact name of Registrant as specified in its charter)

 

N/A

(Translation of the Registrant’s name into English)

 

Cayman Islands

(Jurisdiction of incorporation or organization)

 

No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City

Fujian Province, People’s Republic of China

(Address of principal executive offices)

 

Xuezhu Wang, Chief Executive Officer

Telephone: +86-0599-782-8808

No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City

Fujian Province, People’s Republic of China

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

* Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol   Name of Each Exchange On Which
Registered
Ordinary shares, par value US$0.0005 per share   HAPP   NASDAQ Capital Market

 

Securities registered or to be registered pursuant to Section 12(g) of the Act:

 

None

(Title of Class)

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

 

None

(Title of Class) 

 

 

 

 

The number of outstanding shares of each of the issuer’s classes of capital or common stock as of August 15, 2022 were 66,854,583 Class A ordinary shares, par value $0.0005 per share and 12,245,100 Class B ordinary shares, par value $0.0005 per share.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes ☐ No ☒

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP International Financial Reporting Standards as issued by the
International Accounting Standards Board
Other

  

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: Item 17 ☐ Item 18 ☐

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

Auditor Name: TPS Thayer, LLC   Auditor Location: Sugar Land, TX   Auditor Firm ID: 6706

 

 

 

 

 

 

EXPLANATORY NOTE

 

This Amendment (this “Amendment”) to the annual report on Form 20-F (File No.001-39098), initially filed on August 15, 2022 is being filed as an exhibits-only filing, solely for the purpose of adding Exhibit 23.1, which were inadvertently omitted from the Form 20-F.

 

Other than as expressly set forth above, this Amendment does not, and does not purport to, amend, update or restate any other items or disclosures contained in the Original Filing and does not reflect events occurring after the date of the Original Filing. This Amendment consists solely of the cover page, this explanatory note, the exhibit index and the exhibits filed herewith.

 

 

 

 

ITEM 19. EXHIBITS

 

EXHIBIT INDEX

 

        Incorporated by
reference to
  Filed
Exhibit No.   Description   Form Exhibit Filing Date    herewith
                     
1.1   Original Memorandum and Articles of Association dated March 4, 2019   F-1   3.1   March 8, 2019    
1.2   First Amended and Restated Articles of Association   F-1   3.1   March 28, 2019    
1.3   First Amended and Restated Memorandum of Association   F-1   3.2   March 28, 2019    
1.4   Second Amended and Restated Memorandum and Articles of Association   20-F   1.4   August 15, 2022    
2.1   Specimen Certificate for Ordinary Shares   F-1   4.1   March 28, 2019    
4.1   Employment Agreement by and between CEO Xuezhu Wang and the Company dated August 28, 2018   F-1   10.3   March 28, 2019    
4.2   Employment Agreement by and between CFO Jiong Bian and the Company dated August 26, 2018   F-1   10.4   March 28, 2019    
4.3   Form of Securities Purchase Agreement, by and between Happiness Development Group Limited (formerly known as “Happiness Biotech Group Limited”) and the Purchasers, dated June 25, 2021   6-K   1.1   July 1, 2021    
4.4   Share Purchase Agreement, by and among Happiness Development Group Limited (formerly known as “Happiness Biotech Group Limited”), Fujian Happiness Biotech Co., Limited, and Fujian Shennong Jiagu Development Co., Ltd., dated October 14, 2021   6-K   4.1   October 25, 2021    
4.5   Form of Securities Purchase Agreement, by and between Happiness Development Group Limited (formerly known as “Happiness Biotech Group Limited”) and the Purchasers, dated January 18, 2022   6-K   99.1   January 21, 2022    
4.6   Equity Transfer Agreement, by and among Happiness Development Group Limited (formerly known as “Happiness Biotech Group Limited”), Fujian Happiness Biotech Co., Limited, and Fuzhou Hekangyuan Trading Co., Ltd., dated March 4, 2022   6-K   4.1   March 7, 2022    
4.7   Form of Securities Purchase Agreement, by and between Happiness Development Group Limited (formerly known as “Happiness Biotech Group Limited”) and the Purchasers, dated March 11, 2022   6-K   1.1   March 16, 2022    
8.1   List of Subsidiaries     20-F   8.1   August 15, 2022     
11.1   Code of Business Conduct and Ethics of the Registrant     F-1   99.1   May 3, 2019    
12.1   Certification of the Chief Executive Officer (Principal Executive Officer) pursuant to  Rule 13a-14(a) of the Securities Exchange Act, as amended.               X
12.2   Certification of the Chief Financial Officer (Principal Financial Officer) pursuant to  Rule 13a-14(a) of the Securities Exchange Act, as amended               X
13.1   Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002               X
23.1   Consent of TPS Thayer, LLC               X
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)                

 

1

 

 

SIGNATURE

 

The registrant hereby certifies that it meets all of the requirements for filing on this Amendment to Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

Date: August 18, 2022 HAPPINESS DEVELOPMENT GROUP LIMITED
   
  /s/ Xuezhu Wang
  Xuezhu Wang
  Chief Executive Officer

 

 

2

 

20-F/A 353001 true N/A FY 00000 0001751876 0001751876 2021-04-01 2022-03-31 0001751876 dei:BusinessContactMember 2021-04-01 2022-03-31 0001751876 us-gaap:CommonClassAMember 2022-08-15 0001751876 us-gaap:CommonClassBMember 2022-08-15 xbrli:shares
EX-12.1 2 f20f2022a1ex12-1_happiness.htm CERTIFICATION

Exhibit 12.1

 

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Xuezhu Wang, certify that:

 

  1. I have reviewed this annual report on Form 20-F, as amended, of Happiness Development Group Limited (the “Company”);
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;
     
  4. The Company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

  5. The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

  Date: August 18, 2022
     
    /s/ Xuezhu Wang
  Name:  Xuezhu Wang
  Title: Chief Executive Officer
(Principal Executive Officer)

 

EX-12.2 3 f20f2022a1ex12-2_happiness.htm CERTIFICATION

Exhibit 12.2

 

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Jiong Bian, certify that:

 

  1. I have reviewed this annual report on Form 20-F, as amended, of Happiness Development Group Limited (the “Company”);
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;
     
  4. The Company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

  5. The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

  Date: August 18, 2022

 

    /s/ Jiong Bian
  Name:  Jiong Bian
  Title: Chief Financial Officer
(Principal Financial Officer)

 

EX-13.1 4 f20f2022a1ex13-1_happiness.htm CERTIFICATION

Exhibit 13.1

 

Certifications Pursuant to 18 U.S.C. Section 1350

 

Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Happiness Development Group Limited. (the “Company”), does hereby certify, to such officer’s knowledge, that:

 

The Annual Report on Form 20-F, as amended, for the year ended March 31, 2022 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 18, 2022

 

  /s/ Xuezhu Wang
  Xuezhu Wang
 

Chief Executive Officer

(Principal Executive Officer)

 

Dated: August 18, 2022

 

  /s/ Jiong Bian
  Jiong Bian
 

Chief Financial Officer

(Principal Financial Officer)

 

EX-23.1 5 f20f2022a1ex23-1_happiness.htm CONSENT OF TPS THAYER, LLC

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (file No. 333-253602) and Form F-3 (File No. 333-250026) of our report dated August 15,2022, relating to the consolidated financial statements of Happiness Development Group Limited appearing in its Annual Report on Form 20-F for the period ended March 31, 2022. 

 

 

 

TPS Thayer LLC

 

Sugar Land, Texas

 

August 18, 2022

 

 

EX-101.SCH 6 happ-20220331.xsd XBRL SCHEMA FILE 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.DEF 7 happ-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 happ-20220331_lab.xml XBRL LABEL FILE EX-101.PRE 9 happ-20220331_pre.xml XBRL PRESENTATION FILE GRAPHIC 10 ex23-1_001.jpg GRAPHIC begin 644 ex23-1_001.jpg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htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information - shares
12 Months Ended
Mar. 31, 2022
Aug. 15, 2022
Document Information Line Items    
Entity Registrant Name Happiness Development Group Limited  
Trading Symbol HAPP  
Document Type 20-F/A  
Current Fiscal Year End Date --03-31  
Amendment Flag true  
Amendment Description This Amendment (this “Amendment”) to the annual report on Form 20-F (File No.001-39098), initially filed on August 15, 2022 is being filed as an exhibits-only filing, solely for the purpose of adding Exhibit 23.1, which were inadvertently omitted from the Form 20-F. Other than as expressly set forth above, this Amendment does not, and does not purport to, amend, update or restate any other items or disclosures contained in the Original Filing and does not reflect events occurring after the date of the Original Filing. This Amendment consists solely of the cover page, this explanatory note, the exhibit index and the exhibits filed herewith.  
Entity Central Index Key 0001751876  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Filer Category Non-accelerated Filer  
Entity Well-known Seasoned Issuer No  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus FY  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
ICFR Auditor Attestation Flag false  
Document Registration Statement false  
Document Annual Report true  
Document Transition Report false  
Document Shell Company Report false  
Entity File Number 001-39098  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One No. 11, Dongjiao East Road  
Entity Address, Address Line Two Shuangxi, Shunchang  
Entity Address, Address Line Three Shunchang  
Entity Address, City or Town Nanping City  
Entity Address, Country CN  
Contact Personnel Name Xuezhu Wang  
Entity Address, Postal Zip Code 353001  
Title of 12(b) Security Ordinary shares, par value US$0.0005 per share  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Document Accounting Standard U.S. GAAP  
Auditor Name TPS Thayer, LLC  
Auditor Location Sugar Land, TX  
Auditor Firm ID 6706  
Business Contact    
Document Information Line Items    
Entity Address, Address Line One No. 11, Dongjiao East Road  
Entity Address, Address Line Two Shuangxi  
Entity Address, Address Line Three Shunchang  
Entity Address, City or Town Nanping City  
Entity Address, Country CN  
Contact Personnel Name Xuezhu Wang  
Entity Address, Postal Zip Code 00000  
Contact Personnel Email Address N/A  
Class A Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   66,854,583
Class B Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   12,245,100
XML 12 f20f2022a1_happinessdev_htm.xml IDEA: XBRL DOCUMENT 0001751876 2021-04-01 2022-03-31 0001751876 dei:BusinessContactMember 2021-04-01 2022-03-31 0001751876 us-gaap:CommonClassAMember 2022-08-15 0001751876 us-gaap:CommonClassBMember 2022-08-15 shares false true 2022-03-31 --03-31 2022 false false 001-39098 Happiness Development Group Limited E9 No. 11, Dongjiao East Road Shuangxi, Shunchang Shunchang Nanping City CN Xuezhu Wang Xuezhu Wang No. 11, Dongjiao East Road Shuangxi Shunchang Nanping City CN Ordinary shares, par value US$0.0005 per share HAPP NASDAQ 66854583 12245100 No No Yes Yes Non-accelerated Filer true false U.S. GAAP false false TPS Thayer, LLC Sugar Land, TX 6706 This Amendment (this “Amendment”) to the annual report on Form 20-F (File No.001-39098), initially filed on August 15, 2022 is being filed as an exhibits-only filing, solely for the purpose of adding Exhibit 23.1, which were inadvertently omitted from the Form 20-F. Other than as expressly set forth above, this Amendment does not, and does not purport to, amend, update or restate any other items or disclosures contained in the Original Filing and does not reflect events occurring after the date of the Original Filing. This Amendment consists solely of the cover page, this explanatory note, the exhibit index and the exhibits filed herewith. 20-F/A 353001 true N/A FY 00000 0001751876 EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

+$E4ZJJ+G0 $ #P" / M " :L5 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " !'BQ)5)!Z;HJT M #X 0 &@ @ $8%P >&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'-02P$"% ,4 " !'BQ)599!YDAD! #/ P $P M@ ']%P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" !'&0 " ! end XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 4 40 1 false 3 0 false 1 false false R1.htm 000 - Document - Document And Entity Information Sheet http://happinessbiotech.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: dei:ContactPersonnelEmailAddress, dei:DocumentType, dei:EntityAddressPostalZipCode - f20f2022a1_happinessdev.htm 625, 626, 628, 630 f20f2022a1_happinessdev.htm f20f2022a1ex12-1_happiness.htm f20f2022a1ex12-2_happiness.htm f20f2022a1ex13-1_happiness.htm f20f2022a1ex23-1_happiness.htm happ-20220331.xsd happ-20220331_def.xml happ-20220331_lab.xml happ-20220331_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 19 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f20f2022a1_happinessdev.htm": { "axisCustom": 0, "axisStandard": 2, "contextCount": 4, "dts": { "definitionLink": { "local": [ "happ-20220331_def.xml" ] }, "inline": { "local": [ "f20f2022a1_happinessdev.htm" ] }, "labelLink": { "local": [ "happ-20220331_lab.xml" ] }, "presentationLink": { "local": [ "happ-20220331_pre.xml" ] }, "schema": { "local": [ "happ-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 50, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 7, "total": 7 }, "keyCustom": 0, "keyStandard": 40, "memberCustom": 0, "memberStandard": 3, "nsprefix": "happ", "nsuri": "http://happinessbiotech.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f20f2022a1_happinessdev.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://happinessbiotech.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f20f2022a1_happinessdev.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]", "terseLabel": "Business Contact" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_ContactPersonnelEmailAddress": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Email address of contact personnel.", "label": "Contact Personnel Email Address", "terseLabel": "Contact Personnel Email Address" } } }, "localname": "ContactPersonnelEmailAddress", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name", "terseLabel": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard", "terseLabel": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement", "terseLabel": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report", "terseLabel": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "happ_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://happinessbiotech.com/20220331", "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Class A Ordinary Shares" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "terseLabel": "Class B Ordinary Shares" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://happinessbiotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 1 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r4": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r5": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r6": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" } }, "version": "2.1" } ZIP 20 0001213900-22-049413-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-049413-xbrl.zip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end